CD59 and Buschke-Ollendorff syndrome: Considering high CD59 expression by bronchial epithelial cells and sCD59 release following cellular damage2, 10, we hypothesized that sCD59 may be a marker for inflammatory lung tissue damage predicting BOS incidence and progression.